Teeccino Is Ready for Explosive Growth
Teeccino, a coffee alternative, has achieved product-market fit and is looking for explosive growth in the coming years.
FloSpine’s technology, KeyLift, is a new, minimally invasive treatment for back pain. But the company’s timeline could pose a risk.
My 32-year-old brother recently went through a grueling episode of back pain. In all honesty, it was hard to watch. He couldn’t walk for months or play with his four-year-old daughter. He ended up needing extensive back surgery to alleviate his debilitating pain. No other options were available to him given his pain level.
We all know back pain is going to hit us at some point in life. For some, like my brother, it happens far too early. For others, it may not come until old age.
But we can all agree on one thing: Back pain sucks.
Even worse is making a brutal decision between getting surgery or trying alternative forms of treatment. While getting rods and screws surgically inserted into your spine will alleviate pain, it is an expensive and daunting decision. Other options — like physical therapy, spinal cord stimulators, painkillers, or other types of therapy — can be ineffective.
Simply put, there is no intermediate option for patients who have tried alternative forms of therapy but do not want to have a full-blown surgery to insert rods and screws.
Until now.
FloSpine, the company I’m introducing to you today, has created a revolutionary new device called the KeyLift.
Picture a spine that has two compressed vertebrae that are pinching the nerves.
The KeyLift device clamps onto one of the strongest, thickest parts of the spine (called the lamina). It then expands and releases the compression, providing a chance for instant relief.
The best part? This is a minimally invasive procedure that takes about an hour to complete. And it can be done on an outpatient basis. In other words, no hospital visit or overnight stay is required.
No other company has released a device like this. The closest competitor is Boston Scientific’s Superion product, which was purchased from Vertiflex for $465 million in 2019 with annual sales of around $50 million. The Superion implant doesn’t clamp onto any portion of the spine. It basically just sits in between the vertebrae as a spacer and may migrate over time. In fact, the Superion implant received more than 300 complaints last year on the FDA Maude database. Given its advantages over the Vertiflex Superion implant, FloSpine is in a good position to capture market share with its innovative KeyLift device.
Data-driven startup investment ratings, AI analyst reports, and portfolio company exit and failure tracking
Advanced Search table full access, including ratings and analyst reports.
Charts and trends of capital raised by platform, security type, industry, and more.
Unlock Ratings and AI analyst report filters in the Advanced Company Search.
Track IPOs, acquisitions, failures and other exits for companies in your portfolio.
Teeccino, a coffee alternative, has achieved product-market fit and is looking for explosive growth in the coming years.
Zencastr, despite having just a few months of runway, has an impressive product that solves some major pain points for podcasters.
Remote golf coaching app Skillest is attracting a growing population of golfers with enthusiastic coaches and free advertising.
Sign up for our 3 minute newsletter with fresh takes on the top-rated investments and key startup trends you should know.
We care about the protection of your data. Read our Privacy Policy.